Format

Send to

Choose Destination
See comment in PubMed Commons below
Chem Soc Rev. 2013 May 21;42(10):4459-75. doi: 10.1039/c3cs60056d. Epub 2013 Apr 15.

Development of fucosyltransferase and fucosidase inhibitors.

Author information

1
Institute of Biological Chemistry and Genomics Research Center, Academia Sinica, No.128 Academia Road Section 2, Nan-Kang, Taipei, 11529, Taiwan.

Abstract

L-Fucose-containing glycoconjugates are essential for a myriad of physiological and pathological activities, such as inflammation, bacterial and viral infections, tumor metastasis, and genetic disorders. Fucosyltransferases and fucosidases, the main enzymes involved in the incorporation and cleavage of L-fucose residues, respectively, represent captivating targets for therapeutic treatment and diagnosis. We herein review the important breakthroughs in the development of fucosyltransferase and fucosidase inhibitors. To demonstrate how the synthesized small molecules interact with the target enzymes, i.e. delineation of the structure-activity relationship, we cover the reaction mechanisms and resolved X-ray crystal structures, discuss how this information guides the design of enzyme inhibitors, and explain how the molecules were optimized to achieve satisfying potency and selectivity.

PMID:
23588106
DOI:
10.1039/c3cs60056d
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Royal Society of Chemistry
    Loading ...
    Support Center